Tech Innosphere Engineering Ltd.

www.inno-sphere.com

High-Tech Company

TECH VERTICALS

ADHD, Artificial Intelligence, Healthtech, Life Sciences, Medical Devices, MedTech, Mental Health, Therapeutics, Wearables

General Data

Sector	Medical Devices
Company Stage:	R&D
Established	2015
Number of Employees	10
Employees in Israel	6
Reg. Number:	abCDe

DESCRIPTION

Innosphere is a medical device start-up, developing an innovative wearable medical device for treating and curing ADHD, offering hope for long-term improvement in the quality of life of patients, with no side effects. Based on cutting edge research, Innosphere's noninvasive electrical brain stimulation device provides stimulation to specific brain regions with high accuracy. The stimulation device includes of an array of dry electrodes that are placed on the user's head and allows to activate selected electrodes and stimulation patterns as required.

TECHNOLOGY

Innosphere’s unique technology enables individual control of each electrode, allowing automatic adjustment of electrode characteristics per each user (patent pending) and facilitates tolerance to misplacement of the device by non-experts. This tolerance, reduces the required expertise, and brings the cutting edge neuroscience to the home of the users for applying treatments, with protocols that are personalized to the type and severity of symptoms experienced by each patient.

Products and Phases

Product	Phase
Novostim
Novostim retrains the brain to address the root cause of ADHD, putting kids on a new developmental track. Treatment sessions with Novostim last 20 minutes and take place once a day, for only ten days. Patients wear the Novostim device on their head which gives off gentle electrical stimulation to target specific regions of the brain while the child plays engaging games. This enhances neural activity leading to alleviated ADHD symptoms that can last for weeks after treatment.
First-Gen	Phase I
noninvasive electrical brain stimulation device for stimulating specific brain regions with high accuracy.

	TARGET MARKETS
	Parents to children with ADHD

	BUSINESS MODEL
	B2C

CONTACT INFO

Expand / Collapse All

Main Address: Haifa, Israel

Address	2 Ben-Gurion Ave.
City	Haifa
Country	Israel
Zip	3541414

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Berlin, Germany

Address	53 LuisebstaBe
City	Berlin
Country	Germany
Zip	10117

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Rami Shacour	CEO & Co-Founder
Mr. Ehab Shakour	CTO & Co-Founder
Mr. Yousef Badran	VP, R&D & Co-Founder
Mr. Gabriel Shakour	VP, Regulatory & Clinical Affairs & Co-Founder
Ms. Mirit Nachmani	CFO

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	CEO & Co-Founder, Tech Innosphere Engineering
abC Defghij	Board Member	CTO & Co-Founder, Tech Innosphere Engineering
abC Defghij	Board Member	VP, R&D & Co-Founder, Tech Innosphere Engineering
abC Defghij	Board Member	VP, Regulatory & Clinical Affairs & Co-Founder, Tech Innosphere Engineering
abC Defghij	Board Member	Founder, Salisbury House

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed

Feb. 01, 2016

Seed

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jul. 12, 2022

R&D

abCDe

Co-op with Baylor College of Medicine (Houston, TX).

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Bi-National Fund	abCDe

R&D Grant

Jun. 01, 2019

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2018

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jan. 01, 2016

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Other	abCDe

	Non-Equity Assistance

Expand / Collapse All

Date

Stage

Remarks

Non-Equity Assistance

Jun. 23, 2021

R&D

Contributor	Type	Amount	Remarks
abC Defghij	Municipal Accelerator	abCDe

Non-Equity Assistance

Jul. 01, 2017

R&D

Contributor	Type	Amount	Remarks
abC Defghij	General Accelerator	abCDe

Non-Equity Assistance

Jan. 25, 2017

R&D

Contributor	Type	Amount	Remarks
abC Defghij	Impact Accelerator	abCDe

Non-Equity Assistance

May. 01, 2016

R&D

Contributor	Type	Amount	Remarks
abC Defghij	General Accelerator	abCDe

Last Updated:	abCDe
IVC Number:	abCDe